Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dillon

Showing results (571-580 of 576) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 576 results.
Plos Medicine|March 22, 2017
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard scoreRahul S Desikan, Chun Chieh Fan, Yunpeng Wang, et al.
Journal of Medicinal Chemistry|May 31, 2017
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant CancersGisele A Nishiguchi, Alice Rico, Huw Tanner, et al.
Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of <i>N</i>-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.
Nature Genetics|September 16, 2003
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoniSergio Verjovski-Almeida, Ricardo DeMarco, Elizabeth A L Martins, et al.
The Lancet. Diabetes & Endocrinology|August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialLakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Nature|July 17, 2009
The genome of the blood fluke Schistosoma mansoniMatthew Berriman, Brian J Haas, Philip T LoVerde, et al.
Pageof 58

Showing results (571-580 of 576) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 576 results.
Plos Medicine|March 22, 2017
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard scoreRahul S Desikan, Chun Chieh Fan, Yunpeng Wang, et al.
Journal of Medicinal Chemistry|May 31, 2017
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant CancersGisele A Nishiguchi, Alice Rico, Huw Tanner, et al.
Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of <i>N</i>-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.
Nature Genetics|September 16, 2003
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoniSergio Verjovski-Almeida, Ricardo DeMarco, Elizabeth A L Martins, et al.
The Lancet. Diabetes & Endocrinology|August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialLakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Nature|July 17, 2009
The genome of the blood fluke Schistosoma mansoniMatthew Berriman, Brian J Haas, Philip T LoVerde, et al.
Pageof 58